Alunbrig - Drug for ALK-Positive Lung Cancer 56Overall Response Rate
Liviu Niculescu, MD PhD, Alunbrig - Drug for ALK-Positive Lung Cancer 56% Overall Response Rate at ASCO 2018
Author: Annual-Meeting
Added: 06/07/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts